U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

WASHINGTON >> President Joe Biden today proposed expanding coverage of anti-obesity drugs, like Novo Nordisk’s Wegovy, for more than 7 million people with Medicare and Medicaid health coverage, which ...

Kamath revealed that a 20-year-old woman living in a city today has a 64.6 per cent chance of developing diabetes in her lifetime, while for young men, the risk is 55.5 per cent ...

Injection Pen Market. The global injection pen market is on track for substantial growth, with a forecasted compound annual ...

Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...

Doctors Without Borders, also known as Médecins Sans Frontières (MSF), and organisations representing people with diabetes ...

Doctors Without Borders (MSF) has pinned the blame for South Africa’s current insulin pen shortage on Novo Nordisk. The ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...

As sales of Novo Nordisk’s GLP-1 drugs for diabetes and obesity continue to soar, the Danish drugmaker is once again ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The "Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's ...